Impact of primary immunosuppression on the incidence of infectious complications after orthotopic liver transplantation.
Lohmann
R
R
Department of Surgery, Charité Campus Virchow-Klinikum, Humboldt University Berlin, Berlin, Germany.
Langrehr
J M
JM
Raakow
R
R
Jonas
S
S
Klupp
J
J
Steinmüller
T
T
Neuhaus
R
R
Neuhaus
P
P
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015994:Incidence; D007239:Infections / Q000453:epidemiology*; D016031:Liver Transplantation / Q000276:immunology*; D008297:Male; D011183:Postoperative Complications / Q000453:epidemiology*; D011239:Prednisolone / Q000627:therapeutic use; D012189:Retrospective Studies; D013997:Time Factors
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011239:Prednisolone; C079843:inolimomab; D001379:Azathioprine